Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Industry sector: Computer and Technology
Sector classification: Analytical instruments
Deep Learning based analysis and prediction model for Agilent Technologies, Inc. (A) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for A model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for A.
Model is being retrained on a daily basis.
|% Held by Insiders||NaN%|
|% Held by Institutions||NaN%|
|EPS (last reported FY)||$2.36|
|EPS (last reported Q)||$0.66|
|EPS, estimated (last reported Q)||$0.58|
|Total revenues||$4 B|
|Net income||$1 B|